key: cord-1042138-rx3c8fuv
authors: Park, Jun-Beom; Jung, Kwang-Mook; Piomelli, Daniele
title: Cannabinoids in periodontal disease amid the COVID-19 pandemic
date: 2020-12-08
journal: J Periodontal Implant Sci
DOI: 10.5051/jpis.205006edi01
sha: 42cd71b29e6e5ae02263695cf9c6559adfd96c32
doc_id: 1042138
cord_uid: rx3c8fuv

nan

It is notable that the use of cannabis is associated with a higher prevalence of periodontitis (for a systematic review, see [3] ). Data obtained from the National Health and Nutrition Examination Survey (NHANES) indicate that frequent use of recreational cannabis is positively associated with severe periodontitis, which was observed both in a bivariate analysis and in a multivariable analysis adjusted for demographics (age, sex, race/ethnicity, and income level), alcohol and tobacco use, diabetes mellitus, and past periodontal treatment [4] . Research has also found that cannabis may produce adverse effects on oral tissues including gingival enlargement, nicotinic stomatitis, and uvulitis [5] .

Remarkably, a number of beneficial effects have also been reported. Considerable evidence supports that pharmacological strengthening of the endogenous cannabinoid (endocannabinoid) system may exert beneficial effects on periodontal inflammation and nerve pain [6] . CBD was shown to exert anti-inflammatory and anti-oxidative effects resulting in a faster resolution of oral mucositis in a murine model [7] . Additionally, enhancing endocannabinoid signaling in cells that initiate local immune responses in the periodontium, the periodontal ligament cells, significantly dampened their proinflammatory responses to lipopolysaccharide (LPS) produced by Porphyromonas gingivalis [8] . It has been also shown that selective agonists for type 2 CB (CB 2 ) receptors exert antiinflammatory effects in human periodontal ligament fibroblasts [9] . Finally, pharmacological activation of the endocannabinoid system in periodontal ligament cells exhibited hostprotective effects by both dampening inflammation and preserving cellular integrity, while palmitoylethanolamide, a bioactive lipid structurally related to endocannabinoids, exacerbated inflammation [10] . All in all, these results suggest that targeting the endocannabinoid system, in particular by boosting local CB 2 receptor signaling, may lead to novel therapeutics that improve current treatments for periodontal disease and other oral inflammatory pathologies [11] .

The coronavirus disease 2019 (COVID-19) pandemic due to the worldwide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has significantly affected the use of cannabis in 2 particular human populations, among others. First, it was shown that those who engaged in self-isolation used 20% more cannabis during the pandemic than those who did not, which was associated with self-reported isolation and loneliness [12] . In addition, people with mental health conditions reported increased use of medicinal cannabis by 91% during the COVID-19 pandemic, compared to those with no mental health conditions [13] . Therefore, during the pandemic, health care providers should pay particular attention to oral diseases. Importantly, communication and cooperation between physicians and dental practitioners should be encouraged in managing and treating patients. In addition, the seemingly opposite contribution of the 2 main ingredients of cannabis, THC and CBD, to periodontitis should be kept in mind when addressing the effects of cannabinoids. Certainly, further research is required to evaluate the beneficial and harmful effects of various phytocannabinoids and pharmacological modulators of the endocannabinoid system.

Cannabinoids and endocannabinoids

Cannabinoids and the expanded endocannabinoid system in neurological disorders

Is the use of Cannabis associated with periodontitis? A systematic review and meta-analysis

Relationship between frequent recreational cannabis (marijuana and hashish) use and periodontitis in adults in the United States: National Health and Nutrition Examination Survey

Periodontal and oral manifestations of marijuana use

Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors

Cannabidiol on 5-FUinduced oral mucositis in mice

Methanandamide diminish the Porphyromonas gingivalis lipopolysaccharide induced response in human periodontal ligament cells

Anti-inflammatory activity of cannabinoid receptor 2 ligands in primary hPDL fibroblasts

Analogous modulation of inflammatory responses by the endocannabinoid system in periodontal ligament cells and microglia

Cannabinoid type-2 receptor agonist, inverse agonist, and anandamide regulation of inflammatory responses in IL-1β stimulated primary human periodontal ligament fibroblasts

Self-isolation: a significant contributor to cannabis use during the COVID-19 pandemic

The COVID-19 cannabis health study: results from an epidemiologic assessment of adults who use cannabis for medicinal reasons in the United States